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Abstract 
Purpose: To evaluate the immunomodulatory, antiglycation and anti-ulcerative properties of Ruellia 
squarrosa Fenzl. Acanthaceae. 
Methods: Aerial parts and roots of Ruellia squarrosa were collected and extracted by maceration using 
dichloromethane and methanol as solvents. Luminol-enhanced chemiluminescence assay was used to 
evaluate immunomodulatory activity while antiglycation assay was performed by fluorescence method 
with rutin as standard. Anti-ulcerative activity was evaluated by enzymatic methods, namely, urease 
inhibition and carbonic anhydrase inhibition assays. 
Results: Dichloromethane extract showed immunomodulatory activity with half-maximal inhibitory 
concentration (IC50) of 39.48 ± 8.06 % using ibuprofen as standard and antiglycation effect (IC50 = 
382.21 ± 3.43) using rutin as standard. The methanol extract of the aerial parts of the plant showed 
urease inhibition activity (IC50 = 130.2 ± 0.57) using thiourea as standard. The methanol extract of the 
aerial parts of the plant also showed carbonic anhydrase inhibition activity (IC50 = 1656.7 ± 0.08) using 
acetazolamide as standard. 
Conclusion: It was concluded from the present study that aerial and root extracts of the Ruellia 
squarrosa have significant immunomodulatory, antiglycation and anti-ulcerative properties. 
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Use of plants started with the start of human 
civilization, not only for food purpose, but also for 
healing. The plant materials initially took the form 
of crude drugs such as poultices, powders, 
tinctures, and many other herbal formulations [1]. 
According to WHO, almost 80% of the world’s 
populations depends upon natural products for 
their health [2]. Glycation is involved in several 
diabetes-associated complications like 
retinopathy, neuropathy, and nephropathy. The 
accumulation of glycation end products along 
with proteins compromises their physiological 
functions [3]. The formation of advanced 
glycation end-products (AGEs) progressively 
increases with normal aging and is accelerated in 
diabetes [4]. Organic material of plant origin with 
significant antiglycation activity can be used for 
prevention of diabetic complications. Large 
amounts of reactive oxygen species (ROS) are 
produced by neutrophils and monocytes in 
response to infection which kill microorganisms. 
Excessive ROS concentration is toxic to host 
cells that causes tissue damage and numerous 
inflammatory reactions. Plants that contain 
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immunomodulatory constituents may be used to 
reduce such inflammatory responses [5]. Urease 
catalysis the hydrolysis of urea to form ammonia 
and carbon dioxide; and therefore urease-
inhibitory activity has been designed to quantify 
the end products produced during this reaction. 
The advantageous objective of urease inhibition 
is to reduce the concentration of carbon dioxide 
and ammonia and ultimately reduction in ulcer. 
Carbonic anhydrase inhibition is also correlated 
with anti-ulcerative activity. 
 
Many plants of genus Ruellia have been used as 
diuretic, anti-diabetic, anti-pyretic, analgesic, 
anti-oxidant, anti-hypertensive and gastro-
protective [6,7]. Phytochemical constituents 
which have a wide range of biological activities 
such as glycoside, alkaloids, flavonoids, 
triterpenoids have been reported from genus 
Ruellia [8, 9]. Ruellia squarrosa has recently 
been evaluated for its anticancer activity [10]. 
 
This study was designed to evaluate the 
immunomodulatory, antiglycation and anti-
ulcerative enzyme inhibition activities of 
dichloromethane and methanol extracts of aerial 




Ruellia squarrosa was collected from the area 
near to Bahauddin Zakariya University, Multan.  
Dr. Altaf Ahmed Dasti, from the Institute of Pure 
and Applied Biology, B.Z.U, Multan identified the 
plant. The plant parts were deposited in the 
department’s herbarium with the specimen’s No 
FL.C. 1-2 for future reference. The shaded and 
dried plant material (roots and aerial parts) of 
Ruellia squarrosa was ground and macerated 
with dichloromethane and methanol for three 
days. Both dichloromethane and methanol 
extracts were concentrated by using the Rota 
Vapor. The four extracts used in this study were: 
RSAD (Ruellia squarrosa-Aerial parts-
Dichloromethane extract); RSAM (Ruellia 
squarrosa-Aerial parts-Methanol extract); RSRD 
(Ruellia squarrosa-Roots-Dichloromethane 





We estimated the immunomodulatory activity of 
the extracts by using Luminol-enhanced 
chemiluminescence assay. Fresh blood was 
taken from healthy human volunteers.  25 µL of 
whole blood and 25 µL of the sample in Hank’s 
balanced slat solution (containing MgCl2 and 
CaCl2) were placed in an incubator. Then the 
mixture was dissolved in MeOH (3.1–100 µg/mL) 
and added 25 µL of zymosan, followed by 
chemiluminescence probe luminol (25 µL). Then 
HBSS++ was added to adjust the final volume to 
0.1 ml. The chemiluminescence’s peaks were 





Bovine serum albumin (BSA) solution was 
prepared in 20 µL, 100 mM phosphate buffer 
with 20 µL, 3 mM solution of sodium azide. 
The same concentration was used to prepare 
glucose solution (800 mM). 20 µL, 500 mM of 
dimethyl sulfoxide, 50 µL of BSA, 50 µL of 
glucose, 80µL of phosphate buffer were 
mixed in the well and in the reaction mixture 
was placed in the incubators at 37 ⁰C for one 
week. The sample analysis was performed 
by using spectrophotometer at 440 nm 
wavelength. [12]. Percentage inhibition of 
AGEs (advanced glycation end-products) 
formation was calculated by using Eq 1. 
 
% Inhibition of AGE formation = [1-(Ft /Fc)] × 100 
………… (1) 
 
Anti-ulcerative enzyme inhibition activities 
 
i) Urease inhibition assay: Reaction mixtures 
comprising 25μL of enzyme solution and 55 μL of 
buffers were placed in an incubator with 5 μL of 
the extract for 15-20 minutes in 96-well plates. 
Urease inhibition activity was determined by the 
indophenol method by using spectrophotometer 
and taking absorbance at 625 nm. Thiourea was 
used as the standard inhibitor of urease [13]. 
 
Percentage inhibition was measured by using 
formula given in Eq 2. 
 
% Inhibition = 100-(ODtestwell/ODcontrol) ×100 .. (2) 
 
ii) Carbonic anhydrase inhibition activity: 
Carbonic anhydrase inhibition assay was 
performed according to Ashiq et al with slight 
modification. The total mixture volume was 200 
µL in a well containing 140 μL (20 Mm HEPES 
(Bioworld: Cat# 40820000-1) tris buffer 
(Invitrogen: Cat# 15504-020, pH 7.4), 20 μL of 
the enzyme (Sigma Aldrich, C2624, PCode: 
1001584424) (0.1 - 0.2 mg ̸ mL in deionized 
water); 20 μL (0.5 mg m̸L in DMSO) of test 
compound was mixed and incubated at 25 oC for 
15 min. After incubation pre-read was taken at 
400 nm and 20 μL of substrate (4-nitrophenol 
acetate, Sigma Aldrich, N8130, lot#BCBK4587V) 
(0.7 mM in methanol) was added and re-
incubated at the same condition for 30 min and 
after read was taken at 400 nm. Acetazolamide 
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was taken as positive control. IC50 was calculated 
by making serial dilution of original concentration 
[14]. Inhibition (H) was calculated as given in Eq 
3. 
 




Data collected were analysed using descriptive 
statistics. Comparison of means was achieved 
using one way ANOVA. At 95% confidence 





The dichloromethane extract of aerial parts of the 
plant showed immunomodulatory activity with 
IC50 39.48 ± 8.06 using ibuprofen as standard 
(Table 1). 
 
The dichloromethane extract of the aerial parts of 
the plant showed antiglycation activity (IC50 
382.21±3.43) as compared to standard, rutin 
(IC50 121.68±1.04); while the other extracts of the 
plant showed no activity (Table 2). 
 
The methanol extract of the aerial parts of the 
plant showed urease inhibition activity with 
IC50130.2±0.57 using thiourea as standard 
(Table 3). 
 
The methanol extract of the aerial parts of the 
plant showed carbonic anhydrase inhibition 
activity with IC501656.7 ± 0.08 using 
acetazolamide as standard (Table 4). 
 
 




Concentration (mM)* Inhibition (%) IC50
** 
(µM, mean±SEM) 
RSAM 25  16.57 - 
RSRD - -0.93 - 
RSRM - -0.07 - 
RSAD - 0.01 39.48±88.06 
Ibuprofen 
(standard) 25  3.2 11.2±11.9 
 IC50 = half-maximal inhibitory concentration; RSAD (Ruellia squarrosa- dichloromethane aerial extract); RSAM 
(Ruellia squarrosa- methanol root extract); RSRD (Ruellia squarrosa-roots-dichloromethane extract); and RSRM 
(Ruellia squarrosa methanol root extract) 
 




Concentration (mg/mL) Inhibition (%) IC50 (mg/mL, mean±SEM) 
RSRD 2 18.28 NA 
RSRM 2 39.18 NA 
RSAD 2 65.00 382.21±3.43 
RSAM 2 44.48 NA 
Rutin 2 75.4 121.68±1.04 
IC50 = half-maximal inhibitory concentration; RSAD (Ruellia squarrosa- dichloromethane aerial extract); RSAM 
(Ruellia squarrosa- methanol root extract); RSRD (Ruellia squarrosa-roots-dichloromethane extract); and RSRM 
(Ruellia squarrosa methanol root extract) 
 
Table 3: Urease inhibitor activity of dichloromethane and methanol extracts of Ruellia squarrosa 
 
Sample  Urease inhibitor activity Concentration (mM) Inhibition (%) IC50 (Um, mean±SEM) 
RSRD 0.2 29.8 NA 
RSRM 0.2 43.1 NA 
RSAD 0.2 13.9 NA 
RSAM 0.2 61.9 130.2±0.57 
Thiourea 0.5 99.8 21.2±1.3 
IC50 = half-maximal inhibitory concentration; RSAD (Ruellia squarrosa- dichloromethane aerial extract); RSAM 
(Ruellia squarrosa- methanol root extract); RSRD (Ruellia squarrosa-roots-dichloromethane extract); and RSRM 
(Ruellia squarrosa methanol root extract) 
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Table 4:  Carbonic anhydrase inhibition activity of 









RSRD  23±0.07 - 
RSAM  65±0.07 1656.7±0.08 
RSRM  43±0.02 - 
RSAD  56±0.08 1666.6±0.04 
Acetazolamide 0.1 μMOL 98±0.56 0.031±0.01 
All the samples were dissolved in DMSO. IC50 = half-
maximal inhibitory concentration; RSAD (Ruellia 
squarrosa- dichloromethane aerial extract); RSAM 
(Ruellia squarrosa- methanol root extract); RSRD 
(Ruellia squarrosa-roots-dichloromethane extract); and 




Immunomodulators are chemicals that up-
regulate or down-regulate the immune system. 
Immunomodulators have been accepted as very 
useful drugs because of their wide functions [15]. 
Various disease conditions such as infections, 
organ transplant rejection, cancer, rheumatoid 
arthritis, and systemic lupus erythematosus are 
currently treated with immunomodulating agents 
[16]. Many plants with immunomodulatory 
activities have been reported e.g. Thamnolia 
vermicularis [17]. In this study, aerial parts of the 
methanol extract of R. squarrosa showed a very 
good immunomodulatory activity, five times 
greater than the standard. 
 
Glycation is a condensation reaction between 
sugars and amino groups of proteins and form 
advanced glycation products (AGPs). This 
reaction depends on half-life of the proteins and 
permeability to free glucose [18,19]. AGEs play a 
useful role in diabetic care where it deposits 
under endothelial cells and actually causing the 
decrease in blood sugar concentration. 
Glycoxidation causes protein dysfunction 
suggesting the pathological factor involved in 
diabetes [20,21]. In the present study, 
dichloromethane extract of aerial parts of R. 
squarrosa showed comparable results with the 
standard. 
 
Urease and carbonic anhydrase inhibition are 
correlated with anti-ulcerative activity. Our 





The findings of this study demonstrate that 
Ruellia squarrosa possesses immunomodulatory 
activity and therefore have anti-angiogenic 
properties and thus, may be suitable for the 
treatment of cancer. Its antiglycation and anti-
ulcerative properties indicate that they could find 
use in the treatment of diabetes and gastric 
ulcer, respectively. However, further studies are 
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